TickerFacts.

Company research / JBIO

Jade Biosciences, Inc. (JBIO)

Build a valuation ↗↓ Download CSV

CIK 0001798749

Key ratios (year ended 2025-12-31)

-38.3%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-10

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended2025-12-312024-12-312024-06-172023-12-312022-12-312021-12-312020-12-312019-12-31
Operating Income-$113.54M-$74.60M—-$81.41M-$53.24M-$23.02M-$8.89M—
Net Income-$127.41M-$69.63M—-$75.52M-$51.51M-$22.96M-$9.61M—
EPS (Diluted)$-3.19$-2.44—$-2.87$-2.10$-1.87——
Total Assets$349.78M$72.80M—$127.42M$135.30M$175.36M$4.71M—
Total Liabilities$17.26M$119.60M—$17.96M$8.56M$2.94M$1.77M—
Shareholders' Equity$332.52M-$46.80M$1.0K$109.46M$126.74M$172.42M-$13.34M-$3.64M
Cash & Equivalents$88.44M$69.39M—$23.49M$22.40M$54.20M$4.57M—
Operating Cash Flow-$94.69M-$71.20M—-$56.78M-$39.12M-$27.40M-$7.86M—
Capital Expenditures$196.0K——$142.0K$195.0K$181.0K——
Shares Outstanding49.32M3.67M—27.76M24.72M24.41M243.1K—
Weighted Average Diluted Shares31.36M28.58M—26.33M24.47M12.29M——
EPS (Basic)$-3.19$-2.44—$-2.87$-2.10$-1.87——